ReproTech President Discusses FDA Regulations and Embryo Donation at Nursing Symposium

St. Paul, MN, October 20, 2012 --(PR.com)-- ReproTech President Russ Bierbaum discussed Food and Drug Administration (FDA) guidelines for the donation of tissues, and ReproTech’s Embryo Donation Program at RMIA's Woodbury location. Bierbaum reported that for many couples, their only hope of achieving a full-term pregnancy begins with donated embryos. When continued storage of embryos is no longer practical, some couples will choose to destroy their embryos, while some feel the best choice is to donate their embryos to help other couples achieve pregnancy. ReproTech can facilitate this donation process. ReproTech also offers several Embryo Donation for Research options, and has established relationships with programs across the U.S. which are involved in many different types of research, from basic laboratory research to genomics research to stem cell research.

About Reprotech, Ltd.
ReproTech, Ltd. was founded in 1990 for the purpose of providing long-term cryostorage services and operates cryostorage facilities in Florida, Minnesota, Nevada and Texas. More information on ReproTech, Ltd is available
at www.reprotech.com or 888-489-8944. Information specific to ReproTech’s embryo donation options may be found at www.embryoplacements.com.